McKesson acquiring CoverMyMeds for at least $1.1 billion (updated)
McKesson will pay about $1.1 billion, and an additional $270 million is contingent upon CoverMyMeds financial performance the next two years.
McKesson will pay about $1.1 billion, and an additional $270 million is contingent upon CoverMyMeds financial performance the next two years.
McKesson discussed Conserus at last week's RSNA conference in Chicago.
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
The system connects payer networks to providers and payment systems, breaking down data silos and helping to streamline authorization, claims submission and payments.